具身智能融资火热，灵心巧手获数亿元天使轮融资｜21投融资周报

Group 1 - The core focus of recent financing activities is on embodied intelligence, robotics, and healthcare sectors, indicating strong investor interest in these areas [1][2] - The technology and manufacturing sectors remain the primary focus of the first-level market, with significant financing events reported [2] - A total of 29 financing events occurred in the domestic primary market from August 4 to August 10, with a total scale of approximately 4.12 billion RMB [1] Group 2 - The embodied intelligence and robotics sector completed 7 financing rounds, with disclosed amounts exceeding 790 million RMB, while the biopharmaceutical sector also saw 7 financing rounds totaling over 1.85 billion RMB [2] - Major financing activities were concentrated in Beijing, Guangdong, and Jiangsu provinces, with 9, 6, and 4 financing events respectively [3] Group 3 - Sequoia China and Qiming Venture Partners were notably active, each completing 2 financing rounds primarily in technology, manufacturing, and healthcare sectors [4] Group 4 - Zhejiang Xiangyinong Agricultural Development Co., Ltd. secured 25 million RMB in Series A financing, focusing on the elderly care industry [5] - Ji Tai Technology completed 400 million RMB in Series D financing, aimed at accelerating strategic initiatives including platform automation and product pipeline development [9] - The company Linggan Shike completed two rounds of financing (Pre-A and Pre-A+) with a post-investment valuation exceeding 100 million USD, focusing on intelligent creation tools for content creators [24] Group 5 - The company Yanshengchao completed several rounds of financing to support clinical development and international strategy [10] - The company Zeling Bio secured nearly 400 million RMB in B+ round financing to advance innovative drug development [13] - The company Lifebio completed several rounds of financing to enhance its research and development capabilities in biobased new materials [15]